Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1216 (LINC01216)

Target
LINC01216
Molecular classification
Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA) (a broader family including lincRNAs)
01

Overview

Long intergenic non-protein coding RNA 1216 (LINC01216) is a non-protein-coding RNA gene situated in an intergenic region of the genome, meaning it does not overlap with known protein-coding sequences. LINC01216 is a member of the lincRNA subfamily, which is distinguished by its position away from protein-coding genes and by unique epigenetic and transcriptional regulation. LincRNAs, including LINC01216, influence cellular function by remodeling chromatin, regulating transcription, modulating genome architecture, stabilizing RNA, or acting as enhancers for gene expression. Although thousands of lincRNAs have been annotated, only a minority have been studied in detail; the specific biological and disease roles of LINC01216 remain uncharacterized, with no reported evidence for its consideration as a clinical therapeutic target. LINC01216 is properly named and accurately described as a long intergenic non-protein coding RNA; it is not misclassified nor is there evidence for direct involvement in classical drug targeting or clinical biomarker use.

Other names
EMCN-IT3EMCN intronic transcript 3 (non-protein coding)LINC01216
02

Mechanism of action

Not applicable; drugs targeting LINC01216 are not described.

03

Biological functions

Chromatin remodelingRegulation of genome architectureRNA stabilizationTranscription regulation (including enhancer-like functions)Fine-tuning neighboring gene expression (often tissue-specific)
04

Disease associations

Other (Some lincRNAs are implicated in cancer and other diseases, but no disease association is currently described for LINC01216 specifically)
05

Safety considerations

None currently known or reported in relation to targeting LINC01216.
06

Interacting drugs

None currently known.
07

Biomarkers

None established for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1216 (LINC01216).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1216 (LINC01216).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call